Cargando…

Structure-based design of drugs and other bioactive molecules : tools and strategies /

In contrast to previous texts focusing on either computational, structural or synthetic methods, this one-of-a-kind guide integrates all three skill sets for a complete picture of contemporary structure-based design. As a result, this practical book demonstrates how to develop a high-affinity ligand...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Ghosh, Arun K.
Otros Autores: Gemma, Sandra
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Weinheim : Wiley-VCH, 2014.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ma 4500
001 EBOOKCENTRAL_ocn884646529
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu---unuuu
008 140726s2014 gw ob 001 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d N$T  |d E7B  |d DEBSZ  |d OCLCQ  |d OCLCF  |d RECBK  |d DG1  |d DEBBG  |d OCLCQ  |d EBLCP  |d AZK  |d COCUF  |d DG1  |d MOR  |d CCO  |d LIP  |d PIFAG  |d ZCU  |d MERUC  |d OCLCQ  |d GWDNB  |d U3W  |d OCLCQ  |d STF  |d ICG  |d YDXCP  |d VT2  |d AU@  |d OCLCO  |d OCLCA  |d YOU  |d OCLCO  |d TKN  |d OCLCO  |d OCLCA  |d DKC  |d OCLCO  |d OCLCQ  |d UKAHL  |d OCLCQ  |d OCLCA  |d UKMGB  |d MHW  |d BRF  |d OCLCO  |d OCLCQ  |d OCLCO  |d TUHNV  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO  |d OCLCL 
015 |a GBC074137  |2 bnb 
016 7 |a 1047121190  |2 DE-101 
016 7 |a 1060980886  |2 DE-101 
016 7 |a 106098086X  |2 DE-101 
016 7 |a 016758783  |2 Uk 
016 7 |a 019809008  |2 Uk 
016 7 |a 1047121190  |2 GyFmDB 
019 |a 889557774  |a 889642027  |a 892345090  |a 903291006  |a 961585847  |a 962644829  |a 992918072  |a 1069737146  |a 1081210568  |a 1179744301  |a 1228589761  |a 1244448252  |a 1249226807 
020 |a 9783527665211  |q (electronic bk.) 
020 |a 3527665218  |q (electronic bk.) 
020 |a 9783527665242  |q (electronic bk.) 
020 |a 3527665242  |q (electronic bk.) 
020 |a 3527665234 
020 |a 9783527665235 
020 |z 9783527333653 
020 |z 3527333657 
020 |z 9783527665235 
020 |z 9783527665228 
029 1 |a AU@  |b 000056000714 
029 1 |a CHBIS  |b 010660541 
029 1 |a CHDSB  |b 006246810 
029 1 |a CHNEW  |b 000943375 
029 1 |a CHVBK  |b 480235988 
029 1 |a DEBBG  |b BV043396993 
029 1 |a DEBBG  |b BV043891685 
029 1 |a DEBSZ  |b 414127714 
029 1 |a DEBSZ  |b 424355337 
029 1 |a DEBSZ  |b 485050757 
029 1 |a GWDNB  |b 106098086X 
029 1 |a GWDNB  |b 1060980886 
029 1 |a UKMGB  |b 019809008 
035 |a (OCoLC)884646529  |z (OCoLC)889557774  |z (OCoLC)889642027  |z (OCoLC)892345090  |z (OCoLC)903291006  |z (OCoLC)961585847  |z (OCoLC)962644829  |z (OCoLC)992918072  |z (OCoLC)1069737146  |z (OCoLC)1081210568  |z (OCoLC)1179744301  |z (OCoLC)1228589761  |z (OCoLC)1244448252  |z (OCoLC)1249226807 
037 |a 9783527665235  |b Wiley 
050 4 |a RS431.P38 
060 4 |a 2014 I-322 
060 4 |a QV 745 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a RS  |2 lcco 
072 7 |a MMG.  |2 bicssc 
072 7 |a PN.  |2 bicssc 
082 0 4 |a 615.19  |a 615/.19  |2 22 
049 |a UAMI 
100 1 |a Ghosh, Arun K. 
245 1 0 |a Structure-based design of drugs and other bioactive molecules :  |b tools and strategies /  |c Arun K. Ghosh and Sandra Gemma. 
260 |a Weinheim :  |b Wiley-VCH,  |c 2014. 
300 |a 1 online resource (476 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
504 |a Includes bibliographical references at the end of each chapters and index. 
505 0 |a Structure-based Design of Drugs and Other Bioactive Molecules: Tools and Strategies; Contents; Preface; 1 From Traditional Medicine to Modern Drugs: Historical Perspective of Structure-Based Drug Design; 1.1 Introduction; 1.2 Drug Discovery During 1928-1980; 1.3 The Beginning of Structure-Based Drug Design; 1.4 Conclusions; References; Part One: Concepts, Tools, Ligands, and Scaffolds for Structure-Based Design of Inhibitors; 2 Design of Inhibitors of Aspartic Acid Proteases; 2.1 Introduction; 2.2 Design of Peptidomimetic Inhibitors of Aspartic Acid Proteases. 
505 8 |a 2.8.4 Design of Acyl Guanidine-Based Inhibitors2.8.5 Design of Aminopyridine-Based Inhibitors; 2.8.6 Design of Aminoimidazole- and Aminohydantoin-Based Inhibitors; 2.9 Conclusions; References; 3 Design of Serine Protease Inhibitors; 3.1 Introduction; 3.2 Catalytic Mechanism of Serine Protease; 3.3 Types of Serine Protease Inhibitors; 3.4 Halomethyl Ketone-Based Inhibitors; 3.5 Diphenyl Phosphonate-Based Inhibitors; 3.6 Trifluoromethyl Ketone Based Inhibitors; 3.6.1 Synthesis of Trifluoromethyl Ketones; 3.7 Peptidyl Boronic Acid-Based Inhibitors. 
520 |a In contrast to previous texts focusing on either computational, structural or synthetic methods, this one-of-a-kind guide integrates all three skill sets for a complete picture of contemporary structure-based design. As a result, this practical book demonstrates how to develop a high-affinity ligand with drug-like properties for any given drug target for which a high-resolution structure exists. The authors, both of whom have successfully designed drug-like molecules that were later developed into marketed drugs, use numerous examples of recently developed drugs to present best practice in. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Drug development. 
650 0 |a Bioactive compounds. 
650 0 |a Biopolymers. 
650 0 |a Ligand binding (Biochemistry) 
650 0 |a Protease inhibitors. 
650 0 |a Drugs  |x Structure-activity relationships. 
650 0 |a Drugs  |x Design. 
650 0 |a Molecular structure. 
650 0 |a Structure-activity relationships (Biochemistry) 
650 1 2 |a Drug Design 
650 2 2 |a Molecular Structure 
650 2 2 |a Biopolymers  |x chemistry 
650 2 2 |a Protease Inhibitors  |x chemistry 
650 2 2 |a Structure-Activity Relationship 
650 2 |a Biopolymers 
650 6 |a Médicaments  |x Développement. 
650 6 |a Composés bioactifs. 
650 6 |a Biopolymères. 
650 6 |a Ligands (Biochimie)  |x Fixation. 
650 6 |a Médicaments  |x Relations structure-activité. 
650 6 |a Médicaments  |x Conception. 
650 6 |a Structure moléculaire. 
650 6 |a Relations structure-activité (Biochimie) 
650 7 |a molecular structure.  |2 aat 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Structure-activity relationships (Biochemistry)  |2 fast 
650 7 |a Molecular structure  |2 fast 
650 7 |a Drugs  |x Design  |2 fast 
650 7 |a Bioactive compounds  |2 fast 
650 7 |a Biopolymers  |2 fast 
650 7 |a Drug development  |2 fast 
650 7 |a Drugs  |x Structure-activity relationships  |2 fast 
650 7 |a Ligand binding (Biochemistry)  |2 fast 
650 7 |a Protease inhibitors  |2 fast 
700 1 |a Gemma, Sandra. 
758 |i has work:  |a Structure-based design of drugs and other bioactive molecules (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGGt8GJ88mVmGhpqKcpQdP  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Ghosh, Arun K.  |t Structure-based Design of Drugs and Other Bioactive Molecules.  |d Hoboken : Wiley, 2014  |z 9783527333653 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1744759  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH26885620 
938 |a Askews and Holts Library Services  |b ASKH  |n AH26885670 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL1744759 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL4044465 
938 |a ebrary  |b EBRY  |n ebr10901883 
938 |a EBSCOhost  |b EBSC  |n 815413 
938 |a Recorded Books, LLC  |b RECE  |n rbeEB00596189 
938 |a YBP Library Services  |b YANK  |n 11997958 
938 |a YBP Library Services  |b YANK  |n 11072872 
938 |a YBP Library Services  |b YANK  |n 12679537 
994 |a 92  |b IZTAP